1. Retinal function determined by flicker ERGs before and soon after intravitreal injection of anti-VEGF agents
- Author
-
Gaku Terauchi, Kei Shinoda, Hiroyuki Sakai, Makoto Kawashima, Celso Soiti Matsumoto, Atsushi Mizota, and Yozo Miyake
- Subjects
Aflibercept ,Age-related macular degeneration ,Electroretinogram ,Intravitreal injection ,Macular edema ,Ranibizumab ,Ophthalmology ,RE1-994 - Abstract
Abstract Background To evaluate the retinal function before and soon after an intravitreal injection of an anti-vascular endothelial growth factor (anti-VEGF) agents. Methods Seventy-nine eyes of 79 patients that were treated by an intravitreal injection of an anti-VEGF agent for age-related macular degeneration (AMD), diabetic macular edema (DME), or retinal vein occlusion (RVO) with macular edema (ME) were studied. The RETeval® system was used to record 28 Hz flicker electroretinograms (ERGs) from the injected and non-injected eyes before (Phase 1, P1), within 2 h after the injection (P2), and 2 to 24 h after the injection (P3). Patients were grouped by disease or by the injected agent and compared. The significance of the changes in the implicit times and amplitudes was determined by t tests. Results The amplitudes were not significantly different at the three phases. The implicit time of the injected eye was 31.2 ± 3.2 msec at P1, and it was not significantly different at P2 (31.7 ± 3.1 msec) but it was significantly longer at P3 (32.2 ± 3.3 msec, P
- Published
- 2019
- Full Text
- View/download PDF